LBA57 MHC-II antigen presentation pathway as a predictive biomarker for sintilimab plus chemotherapy in first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer (nsq-NSCLC)

Authors :: Yunpeng Yang
Z. Wang
S. Cang
Q. Yu
R. Ma
Jingyun Fang
Jiaojiao Zhou
Shuang Wang
X. Mei
Gongyan Chen
H. Zhou
B. Peng
Jian Sun
Baolan Li
Zhaohui Yang
Wei Xu
Baohui Han
L. Zhang
Xiubao Ren
M. Bi
Source :: Annals of Oncology. 31:S1186
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Chemotherapy
business.industry
medicine.medical_treatment
Locally advanced
Hematology
Antigen Presentation Pathway
medicine.disease
First line treatment
Oncology
Non squamous
medicine
Cancer research
Non small cell
Lung cancer
business
Predictive biomarker

Full Text Access

Tools